Early Diagnosis of Intracranial Infection After Craniotomy

Sponsor
Pan Jun (Other)
Overall Status
Recruiting
CT.gov ID
NCT04215094
Collaborator
(none)
500
1
18.6
26.8

Study Details

Study Description

Brief Summary

Intracranial infection are serious complications postoperatively in neurosurgical patients. Early identification of these complications is essential to minimize the mortality and moribidy. The aim of this study is observe the postoperative dynamic changes of body temperature (BT), procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) count, and evaluate whether the use of two or more of these markers may improve the diagnostic accuracy of intracranial infection.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: postoperative fever, serum procalcitonin, C-reactive protein and white blood cell coun

Detailed Description

Intracranial infection is a serious complications after neurosurgical operation. Early identification of intracranial infection is important so that, first, optimal treatment is initiated which may improves outcome, second, inappropriate antibiotic treatment and subsequent resistance are prevented, and third, it will promote shorter hospitalization and less cost. In several previous studies, the values of procalcitonin (PCT) and C-reactive protein (CRP) in predicting intracranial infection have been evaluated in neurosurgical patients. However, due to the limited number of studies, the results are not convincing enough and more investigations seems warranted to clarify their dynamic changes in neurosurgical patients without intracranial infection and their role in confirming the suspicion of intracranial infection or excluding intracranial infection from the differential diagnosis.

The aim of the investigator's study is to observe the postoperative dynamic changes of BT, PCT, CRP, and white blood cell (WBC) count, and evaluate whether the use of two or more of these markers may improve the diagnostic accuracy for rational decisions about antibiotic treatment.

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Role of Postoperative Fever, Serum Procalcitonin, C-reactive Protein and White Blood Cell Count in the Diagnosis of Intracranial Infection After Craniotomy
Actual Study Start Date :
Jan 12, 2020
Anticipated Primary Completion Date :
Jul 12, 2021
Anticipated Study Completion Date :
Aug 1, 2021

Arms and Interventions

Arm Intervention/Treatment
infected group

Intracranial infection were diagnosed according to the Centers for Disease Control (CDC) definitions

Diagnostic Test: postoperative fever, serum procalcitonin, C-reactive protein and white blood cell coun
All patients in Intracranial Infection group were cured with antibiotic treatment

non-infected group

the postoperative recovery was uneventful with no infection

Diagnostic Test: postoperative fever, serum procalcitonin, C-reactive protein and white blood cell coun
All patients in Intracranial Infection group were cured with antibiotic treatment

Outcome Measures

Primary Outcome Measures

  1. the diagnosis of intracranial infection after craniotomy [up to 100 weeks]

    Intracranial infection are serious complications postoperatively in neurosurgical patients. Early identification of these complications is essential to minimize the mortality and moribidy. The aim of this study is observe the postoperative dynamic changes of body temperature (BT), procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) count, and evaluate whether the use of two or more of these markers may improve the diagnostic accuracy of intracranial infection

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 68 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. craniotomy of brain tumor;

  2. no clinical manifestations of infection before operation;

  3. no other infection such as respiratory tract infection, urinary tract infection and deep vein catheter infection before the definite diagnosis of intracranial infection ;

  4. the patients had informed consent to enter the study.

Exclusion Criteria:
  1. blood system diseases,respiratory tract infection, urinary tract infection and deep vein catheter infection;

  2. malignant tumors with neuroendocrine characteristicsr;

  3. aspiration, pancreatitis, etc.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Neurosurgery department, Nanfang hospital Guangzhou Guangdong China 510515

Sponsors and Collaborators

  • Pan Jun

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Pan Jun, PHD, MD,Deputy director of Neurosurgery department, Southern Medical University, China
ClinicalTrials.gov Identifier:
NCT04215094
Other Study ID Numbers:
  • SouthernMUC1
First Posted:
Jan 9, 2020
Last Update Posted:
Oct 23, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Pan Jun, PHD, MD,Deputy director of Neurosurgery department, Southern Medical University, China
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 23, 2020